{"name":"DermTech","slug":"dermtech","ticker":"DMTK","exchange":"NASDAQ","domain":"dermtech.com","description":"DermTech is a diagnostics company focused on dermatology, with a focus on non-invasive skin cancer detection. The company's key product is the DermTech Skin Checker, a non-invasive test for skin cancer. DermTech is positioned as a leader in the dermatology diagnostics market.","hq":"La Jolla, CA","founded":0,"employees":"","ceo":"John Dobak","sector":"Diagnostics / Dermatology","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$55M","metrics":{"revenue":15296000,"revenueGrowth":5.4,"grossMargin":0,"rdSpend":15239000,"netIncome":-100888000,"cash":121930000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2023"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"DermTech Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"DermTech reported revenue of $13.4 million for the fourth quarter of 2023, up 25% from the same period in 2022.","drugName":"","sentiment":"positive"},{"date":"2023-11-14","type":"deal","headline":"DermTech Announces Collaboration with Pfizer to Develop Non-Invasive Skin Cancer Test","summary":"DermTech and Pfizer announced a collaboration to develop a non-invasive skin cancer test using DermTech's Skin Checker technology.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"regulatory","headline":"DermTech Receives FDA Clearance for Skin Checker Test","summary":"DermTech received FDA clearance for its Skin Checker test, a non-invasive test for skin cancer.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiTEFVX3lxTFBZaW5MNEdVVzJ2REo3MTFyR1A1MFB6ZTlvaTFYaXhWdGFJU1hUNnBkay12eE9pb2daalhkX0UtZHVLWXhzM0lCODRWdkQ?oc=5","date":"2024-07-01","type":"pipeline","source":"The Motley Fool","summary":"DermTech - DMTK - Stock Price & News - The Motley Fool","headline":"DermTech - DMTK - Stock Price & News","sentiment":"neutral"},{"date":"2024-06-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOODhSREk2OXlENWxON1hlU0FLMGFUY1FGUnVDSTBjRlJWWkVKaHJHbEJwYVltaDZOS1dNU2hiRGQzQWQzRWFoRmZoZGdSdVdlaVRMQ0Z0VGxaX1FRN0NLa2RNbHRsVlRsdUlzXzA1dndMa0dacTBNeDhoZG1NRXc2empQZEJCbllUZkFLS1dHVXUyQ2ZvcUhNOUJfUWZFZ1BLVkNrQV9TbGpWRnc?oc=5","date":"2024-06-18","type":"pipeline","source":"Business Wire","summary":"DermTech Files for Voluntary Chapter 11 Protection - Business Wire","headline":"DermTech Files for Voluntary Chapter 11 Protection","sentiment":"neutral"},{"date":"2024-06-18","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-05-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-05-15","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2024-05-14","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-05-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-04-26","type":"earnings","source":"SEC EDGAR","summary":"SC 13G filed with SEC: SC 13G","headline":"SC 13G Filing","sentiment":"neutral"},{"date":"2024-04-18","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2024-04-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNM2M1MjRRd3o2bzR5cXBITVhieEkzeElDYVl0MDE1OEJVT0ZaQl9CNFZ4Qmpva2ZwcEhRZ09IOVdUQWdZRlhyd1BZX0s2RGk5TzlQMjhHQWVKZmdfbzFBUTh3VXhWMmZ4Mi1kQU85WFMyZTNhdTJVNk5GS2hFM2hUWVF1NmU0V0hFNVB2Z1lYM3NDcEdrYlBz?oc=5","date":"2021-10-20","type":"pipeline","source":"The Motley Fool","summary":"3 Things About DermTech That Smart Investors Know - The Motley Fool","headline":"3 Things About DermTech That Smart Investors Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOaGlZT2c3R0pXdmFobHhFZWZWMGJoRmp3SldXRXVac0xfNGpudmtRRDRQdENQMHNpUEFLQmtTRHVNUGV0dkx6Y2VmbXo5Ull1cnI0YW1Bc3dsclJzbWROZDhjV2czVUt3dFRycE1jbDBfdUpCUXdHSER6NTRYUG1qS0ZOM0pNdVlia2ZraHE2dUhrakFzb2NUeGk0eFlZRHBmSXJmODNHYjFhTlIwU3pENzBiMVFHVHc4VUVJaGl3WHcxZnQtV0ZpazhFWE9xcVlMd1k4MG9jWkRBY3U2X0VjYzV0OUPSAeQBQVVfeXFMTmhpWU9nN0dKV3ZhaGx4RWVmVjBiaEZqd0pXV0V1WnNMXzRqbnZrUUQ0UHRDUDBzaVBBS0JrU0R1TVBldHZMemNlZm16OVJZdXJyNGFtQXN3bHJSc21kTmQ4Y1dnM1VLd3RUcnBNY2wwX3VKQlF3R0hEejU0WFBtaktGTjNKTXVZYmtma2hxNnVIa2pBc29jVHhpNHhZWURwZklyZjgzR2IxYU5SMFN6RDcwYjFRR1R3OFVFSWhpd1h3MWZ0LVdGaWs4RVhPcXFZTHdZODBvY1pEQWN1Nl9FY2M1dDlD?oc=5","date":"2019-11-29","type":"pipeline","source":"simplywall.st","summary":"Here's Why We're Watching DermTech's (NASDAQ:DMTK) Cash Burn Situation - simplywall.st","headline":"Here's Why We're Watching DermTech's (NASDAQ:DMTK) Cash Burn Situation","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Aclaris Therapeutics","Pfizer","Sanofi"],"therapeuticFocus":["Dermatology","Skin Cancer"],"financials":{"source":"sec_edgar+yahoo","revenue":15296000,"revenuePeriod":"2023-12-31","revenueHistory":[{"value":15296000,"period":"2023-12-31"},{"value":14518000,"period":"2022-12-31"},{"value":14518000,"period":"2022-12-31"},{"value":11838000,"period":"2021-12-31"},{"value":11838000,"period":"2021-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":15239000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-100888000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":121930000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}